Integrated fluidic circuits for high-throughput bioassays
Fluidigm Corporation develops and manufactures bioanalytical systems that leverage the unique properties of integrated fluidic circuits (IFCs). The novel device is fabricated through a process called multilayer soft lithography (MSL process), in which microscopic vias, valves, channels, and chambers are molded within bonded layers of elastomer. Compared to other technologies, such as microplates and robotics, IFCs are vastly more efficient for large-scale biology and represent an elegant solution to a need for greater throughput with smaller sample volumes. The potential markets for IFC-based platforms include genomics, proteomics, and early detection of biological threats.
Fluidigm was founded in 1999 by Gajus Worthington and Dr. Stephen Quake, whose laboratory at the California Institute of Technology invented the MSL process.
Technology Practice Area
Physical and Biological Technologies |
Location
San Francisco, CA |
Initial Investment
June 2004
|
Website
www.fluidigm.com |
Press Release
Click Here |
|
